TNFRSF13B and peripheral arterial disease: Since the discovery of the association of PAD with genetic variants in TNFRSF13B (1, 14, 28), it has been noted that ∼10% of PAD patients carry these heterozygous variants, but their penetrance appears to be incomplete, as ∼1% of the healthy population also carry these variants (27).